Managing complex medical conditions often requires the simultaneous use of multiple different drugs, referred to as polypharmacy. While necessary, this significantly increases the risk of drug-drug ...
A research team co-led by scientists at the Netherlands Cancer Institute (NKI) and Oncode Institute has developed a deep learning model, PARM (promoter activity regulatory model) that offers up new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results